MPR Weekly Dose

MPR Weekly Dose 100 - Paxlovid EUA submission; Drugs linked to orthostatic hypotension; Besremi approved; Pill for remote endoscopy; Largest psilocybin trial to date

Nov 19, 2021

We made it to 100! This week Pfizer seeks Emergency Use Authorization for their COVID oral antiviral; A meta-analysis found commonly prescribed drugs were linked to orthostatic hypotension; A novel treatment is approved for polycythemia vera; A new program has been cleared to allow individuals to carry out remote...

MPR Weekly Dose 99 - Oral COVID-19 candidate reduces risk of death; aromatherapy sprays recalled; Presbyopia Tx; Naloxone alternative; Migraine drug head-to-head study

Nov 12, 2021

This week there’s positive news for the COVID-19 oral antiviral candidate, Paxlovid; The CDC expands a recall for aromatherapy sprays connected to fatal cases of a rare tropical disease; The first eye drop to treat presbyopia is approved; An alternative to naloxone gets fast tracked; And a study compares the migraine...